Evidence map›Paper›PMID 40365721›Full record

ArticleCNS neuroscience & therapeutics2025

Deep Brain Stimulation in Parkinson's Disease Patients Over 75 Years of Age: A Single-Institution Retrospective Analysis.

Xin Wang, Jing Wang, Nan Li, Yuqi Wen, Bao Wang, Huijuan Kou, Jian Fu, Hongwen Qu, Chun Qiu, Zixuan Jing and 4 more

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xin WangDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.ORCID 0000-0002-5489-7963
Jing WangDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Nan LiDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Yuqi WenDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Bao WangDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Huijuan KouDepartment of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Jian FuDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Hongwen QuDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Chun QiuDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Zixuan JingXi'an Medical University, Xi'an, Shaanxi, China.
Mingming SuDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Zhaohui ZhengDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Xuelian WangDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Yan QuDepartment of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.ORCID 0000-0001-5434-7390

Funding

Key Research and Development Projects of Shaanxi Province 2024SF-YBXM-073Rapid Response Research Project of Air Force Medical University 2023KXKT053Xi'an Science and Technology Plan Project 24KPZT0006
6 · The paper itself

Abstract

aimElderly patients (aged 75 years and older) with Parkinson's disease (PD) are commonly considered unsuitable for deep brain stimulation (DBS) because of its limited benefits for this population and high risk. Understanding therapeutic heterogeneity in terms of effectiveness and safety can help in personalized prognostic and preoperative evaluations.

methodsThe clinical data of 1680 PD patients who underwent DBS surgery in our hospital between April 2007 and July 2023 were retrospectively analyzed. Sixty-eight of the patients were aged 75 years or older at the time of treatment. The patients were stratified into two groups according to the disease duration: 38 had PD for < 10 years, and 30 had PD for ≥ 10 years. The baseline data, including sex, Hoehn-Yahr scores, PD classification, comorbidities, levodopa responsiveness, anesthesia and operation methods, were compared to confirm the comparability of the results. The Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale-part 3 (MDS-UPDRS-III) score (off- or on-medication condition, off-medication/on-stimulation condition, and on-medication/on-stimulation condition), levodopa equivalent daily dose (LEDD), 39-item Parkinson's disease questionnaire (PDQ-39) score, activities of daily living (ADL) scale score, and adverse events were obtained and compared between the two groups preoperatively and at the postoperative follow-up.

resultsAmong the two groups of patients, no significant differences in sex, PD classification, comorbidities, levodopa responsiveness, anesthesia method, or operation method were observed. In both groups of patients, the postoperative MDS-UPDRS-III scores were significantly lower than the preoperative MDS-UPDRS-III scores. However, the LEDD, PDQ-39 score, and ADL score did not decrease significantly in patients with a disease duration ≥ 10 years. The incidence rate of complications was significantly higher in this group of patients.

conclusionsDBS surgery is effective for improving motor symptoms in elderly PD patients (aged 75 years and older) in the short and long term. Patients with a longer duration of disease (≥ 10 years) cannot easily reduce the use of anti-Parkinsonian drugs, improve their quality of life, or improve their ability to perform daily living activities. These PD patients often suffer relatively more temporary complications, which should be taken seriously by doctors.

Indexed as

Deep Brain StimulationParkinson DiseaseAgedAged, 80 and overFemaleHumansMaleRetrospective StudiesTreatment Outcomeadvanced agedeep brain stimulationdisease durationParkinson's diseasetherapeutic effect

Identifiers

PMID40365721
PMCPMC12076122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.